 |
 |
 |
| Figure 1. Plethora of the face | Figure 2. Plathoric mucosa | Figure 3. Palmar erythrma |
This 50 year old male presented with an incidentally diagnosed haemoglobin of 21.2g/dL. He had no symptoms. Despite a dark complexion the malar plethora its evident. Mucosal plethora and palmar erythrma is evident.
Pomalidomide has been accelerated approved by US FDA for multiple myeloma that has progressed on at least two previous therapies including bortezomib and lenalidomide, within 60 days of the last therapy. The approval was based on the multicenter, randomized, open-label study CC-4047-MM-002. The approval is based on response rates. Pomelidomide has not been as yet shown to […]
